SandraMarcheseJohnsonMD
Dermatology • Fort Smith, ARDermatologic Surgery, Dermatopathology, Pediatric Dermatology
Dermatologist in practice with husband www.johnsondermatology.com
Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5921 Riley Park Dr
Fort Smith, AR 72916Phone+1 479-420-1221Fax+1 479-646-0133
Education & Training
University of Arkansas for Medical Sciences (UAMS) College of MedicineInternship, Internal Medicine, 1996 - 1997
Northeast Ohio Medical UniversityClass of 1996
Northeastern Ohio Universities College of MedicineClass of 1996
Certifications & Licensure
AR State Medical License 1997 - 2025
OK State Medical License 2024 - 2025
OH State Medical License 2004 - 2006- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis Start of enrollment: 2018 Feb 20
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Roles: Principal Investigator
- Candin for the Treatment of Common Warts Start of enrollment: 2024 Mar 05
Roles: Contact
Publications & Presentations
PubMed
- 23 citationsNecrolytic migratory erythema as the only presenting sign of a glucagonoma.Sandra Marchese Johnson, Bruce R. Smoller, Laura W. Lamps, Thomas Horn
Journal of the American Academy of Dermatology. 2003-08-01 - 64 citationsRandomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acneJerry Tan, Diane Thiboutot, Georg Popp, Melinda Gooderham, Charles Lynde
Journal of the American Academy of Dermatology. 2019-06-01 - 6 citationsA Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris.James Q Del Rosso, Sandra Marchese Johnson, Todd Schlesinger, Lawrence Green, Nestor Sanchez
The Journal of Clinical and Aesthetic Dermatology. 2022-07-01
Books/Book Chapters
Press Mentions
Rosacea Commonly UnderdiagnosedFebruary 12th, 2020
FDA Approves AkliefDecember 9th, 2019
FDA Approves New Topical Cream to Treat AcneOctober 4th, 2019- Join now to see all
Grant Support
- Immunotherapy And Science Of Warts Using Intralesional Skin Test AntigensNational Center For Research Resources2005
- Immunotherapy Of Warts--Intralesional Skin Test AntigensNational Center For Research Resources2004
- Immunotherapy Of WartsNational Center For Research Resources2004
Professional Memberships
- Fellow
- Fellow
External Links
- Johnson Dermatologyhttp://Www.johnsondermatology.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
